Photo from wikipedia
In liver transplantation (LT), improvements in surgical techniques, immunosuppression strategies, and infection management have extended the lifespan of both the graft and the patient. In 2021, cardiac disease is the… Click to show full abstract
In liver transplantation (LT), improvements in surgical techniques, immunosuppression strategies, and infection management have extended the lifespan of both the graft and the patient. In 2021, cardiac disease is the leading contributor to healthcare utilization and morbidity after LT (1). This observation is a result of performing transplants in patients of older age, the rise of non-alcoholic steatohepatitis as a leading indication for transplantation and the relationship between the unique physiology of cirrhosis and pathologic changes in myocardial structure and function (2).
Journal Title: Liver Transplantation
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!